University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center — Dallas, Texas

University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center is a clinical research site located in Dallas, Texas, United States 75235.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B-Cell Lymphoma.

Sponsors: Denovo Biopharma LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center?

University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center conducted?

University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center has 1 clinical trials on record. Their work covers Diffuse Large B-Cell Lymphoma.

Is University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center accredited by Crixeo Health?

University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.